앱셀레라바이오로직스 (ABCL)

AbCellera Biologics Inc (ABCL) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	39.10% 9.179	6.599	10.06	12.19	21.55
Operating Expenses	22.35% 75.23	61.49	61.45	77.07	59.32
Benefits Costs and Expenses	25.95% 57.78	45.88	48.06	60.34	52.96
Costs And Expenses	25.95% 57.78	45.88	48.06	60.34	52.96
Depreciation and Amortization	31.40% 7.536	5.735	5.61	5.514	-
Operating Income/Loss	20.34% -66.05	-54.89	-51.39	-64.87	-37.78
Nonoperating Income/Loss	11.77% 17.45	15.61	13.38	16.73	6.366
Income/Loss From Continuing Operations Before Tax	23.74% -48.60	-39.28	-38.00	-48.15	-31.41
Income Tax Expense/Benefit	86.39% -1.452	-10.67	-7.476	-8.038	-1.519
Income/Loss From Continuing Operations After Tax	64.80% -47.15	-28.61	-30.53	-40.11	-29.89
Net Income/Loss	64.80% -47.15	-28.61	-30.53	-40.11	-29.89
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.86% 0.4161	289.50	288.91	287.77	0.417
Diluted Average Shares	99.86% 0.4161	289.50	288.91	287.77	0.6433
Basic Earnings Per Share	70.00% -0.17	-0.10	-0.11	-0.14	-0.10
Diluted Earnings Per Share	70.00% -0.17	-0.10	-0.11	-0.14	-0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-